Ask to take part

Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.

Contact Information:

Helen Reeve-Stoffer, PhD +44 (0) 794 774 8006
hreeve-stoffer@recormedical.com


Lea Doyle +1 352 362 1021
Lea.Doyle@recormedical.com


Study Location:

Find another location


Questions to ask
Skip to Main Content
English | Cymraeg
Be Part of Research - Trial Details - The "Global Paradise System" Registry
Back

The "Global Paradise System" Registry

Recruiting

Open to: ALL

Age: 18.0 - N/A

Bournemouth Canterbury Cardiff Glasgow London London Newcastle

Medical Conditions

Hypertension

This information is provided directly by researchers, and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information. In some summaries, you may come across links to external websites. These websites will have more information to help you better understand the study.


The GPS Registry is a multi-centre, single-arm, non-interventional (observational) registry. In addition to collecting data from patients treated as per standard clinical practice, the Registry will also regularly collect telemetric Home Blood Pressure (HBP) measurements and Patient Reported Outcome (PRO) data via a standardized quality of life questionnaire. The objective of the GPS Registry is to document the long-term safety and effectiveness of the commercially available Paradise Ultrasound Renal Denervation System when used per its labelling in patients deemed to be candidates for RDN as per physician's assessment.

Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.  

The recruitment start and end dates are as follows:

Jan 2022 Dec 2030

OBSERVATIONAL

Intervention Type : DEVICE
Intervention Description : The CE-marked and commercially available ReCor Medical Paradise Ultrasound Renal Denervation System (Paradise System) is a catheter-based device designed to use ultrasound energy to thermally ablate the nerves surrounding the renal artery and serving the kidney.

Intervention Arm Group : Renal Denervation Treatment;



You can take part if:



You may not be able to take part if:


This is in the inclusion criteria above


Below are the locations for where you can take part in the trial. Please note that not all sites may be open.

  • Royal Bournemouth Hospital, Bournemoth
    Bournemouth
  • Kent and Canterbury Hospital, Canterbury
    Canterbury
  • University Hospital Wales, Cardiff
    Cardiff
  • Queen Elizabeth Hospital, Glasgow
    Glasgow
  • Hammersmith Hospital (Imperial College Healthcare NHS Trust)
    London
  • WHRC - Barts Health, London
    London
  • Freeman Hospital, Newcastle
    Newcastle

Helen Reeve-Stoffer, PhD +44 (0) 794 774 8006
hreeve-stoffer@recormedical.com


Lea Doyle +1 352 362 1021
Lea.Doyle@recormedical.com



The study is sponsored by ReCor Medical, Inc.



We'd like your feedback

Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.


Is this study information helpful?

What will you do next?
Read full details for Trial ID: NCT05027685
Last updated 05 July 2023

This page is to help you find out about a research study and if you may be able to take part

You can print or share the study information with your GP/healthcare provider or contact the research team directly.   

Back to the top